COVID-19 Seropositivity Among Adults of Tribal Origin Attending a Primary Care Centre in Wayanad Kerala- A Cross Sectional Study

Abstract

Introduction: Coronavirus Disease-2019 (COVID-19) is a highly contagious viral illness caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Serological surveys help in understanding the burden of past infections. The World Health Organisation (WHO) suggests the need for populationbased sero-epidemiological investigations to acquire data for implementing containment measures. The tribal population, being the most marginalised and vulnerable section, is at a higher risk for COVID-19. However, there is limited literature regarding the seroprevalence of COVID-19 among the tribal population in our country. Aim: To assess the COVID-19 seropositivity, associated factors, and knowledge among adults of tribal origin attending a primary care centre in Wayanad, Kerala. Materials and Methods: A cross-sectional study was conducted among 279 adults of tribal origin, aged between 18 and 95 years, attending a primary tribal healthcare centre at Amrita Institute of Medical Sciences, Kochi, Kerala, India, from August 2021 to October 2021. A semistructured questionnaire was used to collect socio-demographic details, history of COVID-19 infection, vaccination status, and participants’ knowledge and awareness about COVID-19. Antibody presence was tested using the WANTAI test kit. Data analysis was performed using Statistical Package for Social Sciences(SPSS) version 21.0 A multivariable logistic regression was conducted following univariate analysis to identify independent factors associated with COVID-19 seropositivity. Results: The mean age of the study population was 45.34±15.86 years. Among the 279 participants, the proportion of seropositivity to COVID-19 antibodies was found to be 245 (87.8%) with a 95% confidence interval (CI) of 83.98 to 91.62. Regarding knowledge and awareness related to COVID-19, 186 (66.7%) participants were not aware of the common symptoms of COVID19. Individuals aged above 60 years had a five times higher probability of having COVID-19 antibodies compared to those aged 30 years or younger (adjusted odds ratio (aOR) 4.71, 95% CI 0.111 to 20.025). Those who had received atleast one dose of the vaccine were nine times more likely to have seropositivity (aOR 8.58, 95% CI 1.390 to 53.028). Conclusion: The seropositivity of COVID-19 was high at 87.8%. Older people and vaccinated individuals were more likely to be seropositive. Therefore, it is necessary to strengthen vaccination efforts among all age groups. Continued sero-surveillance and vaccination surveys need to be conducted to gain more insights into the antibody kinetics of this novel pathogen.

Keywords

• antibody
• seroprevalence
• vaccination coronavirus disease-2019